NorthWest Healthcare Properties REIT makes offer for Australian trust
Business Related
Yes
AUHPT owns 62 hospitals, medical office buildings and other health-care facilities.
The deal requires AUHPT unitholder approval.
Including the REIT’s directly held units, the bidding consortium owns 5.1 per cent of the aggregate value of issued and outstanding AUHPT units and has options for an additional 11.1 per cent.
It says it is AUHPT’s largest beneficial unitholder.
Toronto-based NorthWest Healthcare holds a portfolio with interests in 186 properties in Canada, Brazil, Europe, Australia and New Zealand.
This report by The Canadian Press was first published May 31, 2021.
Companies in this story: (TSX:NWH.UN)
TORONTO NorthWest Healthcare Properties Real Estate Investment Trust says it and a partner have made an offer to buy Australian Unity Healthcare Property Trust that values it at $2.6 billion, including debt. AUHPT owns 62 hospitals, medical office buildings and other health-care facilities. The deal requires AUHPT unitholder approval. Including the REIT’s directly held […]
TORONTO - NorthWest Healthcare Properties Real Estate Investment Trust says it and a partner have made an offer to buy Australian Unity Healthcare Property Trust that values it at $2.6 billion, including debt.
/CNW/ - NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (the "REIT") announced today that the Trustees of the REIT have declared a.
Northwest Healthcare Properties Real Estate Investment Trust Releases First Quarter 2021 Results
News provided by
Share this article
Share this article
TORONTO, May 13, 2021 /CNW/ - NorthWest Healthcare Properties Real Estate Investment Trust (the REIT ) (TSX: NWH.UN), Canada s leading global diversified healthcare real estate investment trust, today announced its results for the three months ended March 31, 2021.
Commenting on the activity, Paul Dalla Lana, CEO of the REIT, said: 2021 has gotten off to a strong start with the REIT raising approximately $280 million of new equity and significantly reducing leverage, advancing its life sciences strategy with inaugural acquisitions in both Canada and Europe, as well as strong momentum in its global asset management initiatives.